https://scholars.lib.ntu.edu.tw/handle/123456789/642296
標題: | Drug evaluation: ADI-PEG-20 - A PEGylated arginine deiminase for arginine-auxotrophic cancers | 作者: | LI-JIUAN SHEN Shen, Wei-Chiang |
公開日期: | 六月-2006 | 卷: | 8 | 期: | 3 | 起(迄)頁: | 240 | 來源出版物: | Current opinion in molecular therapeutics | 摘要: | Pheonix is developing ADI-PEG-20, a PEGylated arginine deiminase for the potential treatment of hepatocellular carcinoma, for which the Food and Drug Administration (FDA) and the European Agency for the Evaluation of Medicinal Products have granted the drug Orphan Drug status, and melanoma, for which the FDA has also awarded ADI-PEG-20 Orphan Drug status. ADI-PEG-20 is also being investigated for the potential treatment of influenza virus infection and hepatitis C virus infection. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/642296 | ISSN: | 1464-8431 |
顯示於: | 藥學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。